Replies to post #78990 on Cytodyn Inc (CYDY)

[Blane]

The cardiovascular pathologies had been addressed in Dr Yo and Dr Mike’s interview with Dr. Bruce Patterson.

RANTES appears to be the main driver of most, if not all, the pathologies associated with Covid, including coagulopathies. Since Leronlimab mitigates this process at the top of the immune response chain, any other drug is likely unneeded.

#Leronlimab for the win.

[Blane]

Don’t have private message.

Here’s my response:

Clinical trial data is still in progress. However, Dr. Patterson’s paper submitted for publication is widely available. You want a link? How about picking up a basic pathophysiology book and following the CCR5 pathway in the inflammatory process. It’s really not that difficult.

I’ll follow that up with this:

Clinical trial data for cancer has been shared In previous presentations, as much as they could share due to Covid limitations. But the MOA is well understood as it relates to cancer, with even some more added benefits discovered during the process. The MOA? It blocks CCR5.

HIV: Well demonstrated MOA. HIV patients 5 years+ still undetectable. Why? Because of the MOA. It blocks CCR5.

Wow. How does it work in Covid? It blocks CCR5.

If you follow the CCR5 pathway, then it’s understood what it will do. Just because data from the trial hasn’t yet been printed on paper, doesn’t mean that Dr Brice Patterson is lying. Why should he? The MOA is simple. It blocks CCR5.

Get out a basic anatomy and physiology book and follow it yourself. Link? Try studying it. The “paper” is for the fda and scientific authorities. But for many on this board, and BP, JL, and others in the medical profession... all they need to know is it’s MOA. The rest is left for physiology to reveal.

Want a link? You’ll need to wait a few weeks. For many here, the matter is pretty much settled because we understand the science. Not saying you don’t, but Leronlimab has been proving itself to do what it does: block CCR5.